Search for: "SEC v. Downe" Results 1601 - 1620 of 1,760
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
15 Sep 2020, 3:03 pm by Kevin LaCroix
[v] Thinking we would need to work our way through the details of complying with the current statutory conflict-of-interest safe harbors of Chapter 607, we consulted with Gary Teblum, my partner who was active in the recent revision of Chapter 607. [read post]
30 Oct 2015, 7:48 am by Rebecca Tushnet
  No disclosure has ever been struck down under Zauderer. [read post]
28 Mar 2012, 6:54 am by Durga Rao Vanayam
A Constitution Bench of the Supreme Court in M.Karunanidhi v. [read post]
13 May 2020, 9:02 pm by Guest Contributor
At this point, the repercussions of all plants shutting down in this country would push recovery from months to years. [read post]
22 Jan 2013, 10:56 am by Michael Froomkin
The Supreme Court recently addressed this very issue in Free Enterprise Fund v. [read post]
24 Feb 2009, 8:10 am
EA excluded the proposal from the company's ballot, and the case focuses on whether the SEC's shareholder proposal rule (Rule 14a-8) allows the company to do so. [read post]